Disease-relevant intracellular protein-protein interactions occurring at defined cellular sites possess great potential as drug targets. They permit highly specific pharmacological interference with defined cellular functions. Drugs targeting such interactions are likely to act with fewer side effects than conventional medication influencing whole cell functions.
This book discusses therapeutically relevant protein-protein interactions with a major focus on scaffolding proteins tethering signal transduction processes to defined cellular compartments by direct protein-protein interactions. Recent advances in the development of pharmacological agents interfering with protein-protein interactions are highlighted.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
Disease-relevant intracellular protein-protein interactions occurring at defined cellular sites possess great potential as drug targets. They permit highly specific pharmacological interference with defined cellular functions. Drugs targeting such interactions are likely to act with fewer side effects than conventional medication influencing whole cell functions.
This book discusses therapeutically relevant protein-protein interactions with a major focus on scaffolding proteins tethering signal transduction processes to defined cellular compartments by direct protein-protein interactions. Recent advances in the development of pharmacological agents interfering with protein-protein interactions are highlighted.
Imprint | Springer-Verlag |
Country of origin | Germany |
Series | Handbook of Experimental Pharmacology, 186 |
Release date | October 2010 |
Availability | Expected to ship within 10 - 15 working days |
First published | 2008 |
Editors | Enno Klussmann, John Scott |
Dimensions | 235 x 155 x 27mm (L x W x T) |
Format | Paperback |
Pages | 512 |
Edition | Softcover reprint of hardcover 1st ed. 2008 |
ISBN-13 | 978-3-642-09194-0 |
Barcode | 9783642091940 |
Categories | |
LSN | 3-642-09194-6 |